Literature DB >> 25785426

GPCRs: Heterodimer-specific signaling.

Marc Parmentier1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25785426     DOI： 10.1038/nchembio.1772

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  8 in total

1.  A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.

Authors:  Maria Waldhoer; Jamie Fong; Robert M Jones; Mary M Lunzer; Shiv K Sharma; Evi Kostenis; Philip S Portoghese; Jennifer L Whistler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

2.  D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.

Authors:  Asim J Rashid; Christopher H So; Michael M C Kong; Teresa Furtak; Mufida El-Ghundi; Regina Cheng; Brian F O'Dowd; Susan R George
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

Review 3.  Dimerization in GPCR mobility and signaling.

Authors:  Martin J Lohse
Journal:  Curr Opin Pharmacol       Date:  2009-11-10       Impact factor: 5.547

Review 4.  Manipulating signaling at will: chemically-inducible dimerization (CID) techniques resolve problems in cell biology.

Authors:  Robert DeRose; Takafumi Miyamoto; Takanari Inoue
Journal:  Pflugers Arch       Date:  2013-01-09       Impact factor: 3.657

5.  Involvement of G-protein βγ subunits on the influence of inhibitory α2-autoreceptors on the angiotensin AT1-receptor modulation of noradrenaline release in the rat vas deferens.

Authors:  Carlos Talaia; Glória Queiroz; Helder Pinheiro; Daniel Moura; Jorge Gonçalves
Journal:  Neurochem Int       Date:  2006-09-07       Impact factor: 3.921

6.  Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling.

Authors:  Morgane Bellot; Ségolène Galandrin; Cédric Boularan; Heinrich J Matthies; Fabien Despas; Colette Denis; Jonathan Javitch; Serge Mazères; Samra Joke Sanni; Véronique Pons; Marie-Hélène Seguelas; Jakob L Hansen; Atul Pathak; Aurelio Galli; Jean-Michel Sénard; Céline Galés
Journal:  Nat Chem Biol       Date:  2015-02-23       Impact factor: 15.040

7.  Class A G-protein-coupled receptor (GPCR) dimers and bivalent ligands.

Authors:  Christine Hiller; Julia Kühhorn; Peter Gmeiner
Journal:  J Med Chem       Date:  2013-06-04       Impact factor: 7.446

Review 8.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.

Authors:  Jean-Philippe Pin; Richard Neubig; Michel Bouvier; Lakshmi Devi; Marta Filizola; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Krzysztof Palczewski; Marc Parmentier; Michael Spedding
Journal:  Pharmacol Rev       Date:  2007-03       Impact factor: 25.468
  8 in total
  4 in total

1.  Luminal ANG II is internalized as a complex with AT1R/AT2R heterodimers to target endoplasmic reticulum in LLC-PK1 cells.

Authors:  Fernanda M Ferrão; Luiza H D Cardoso; Heather A Drummond; Xiao C Li; Jia L Zhuo; Dayene S Gomes; Lucienne S Lara; Adalberto Vieyra; Jennifer Lowe
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-03

Review 2.  Contribution of heteromerization to G protein-coupled receptor function.

Authors:  Supriya A Gaitonde; Javier González-Maeso
Journal:  Curr Opin Pharmacol       Date:  2016-11-09       Impact factor: 5.547

Review 3.  Clarifying the Ghrelin System's Ability to Regulate Feeding Behaviours Despite Enigmatic Spatial Separation of the GHSR and Its Endogenous Ligand.

Authors:  Alexander Edwards; Alfonso Abizaid
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

4.  A Web Server for GPCR-GPCR Interaction Pair Prediction.

Authors:  Wataru Nemoto; Yoshihiro Yamanishi; Vachiranee Limviphuvadh; Shunsuke Fujishiro; Sakie Shimamura; Aoi Fukushima; Hiroyuki Toh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 6.055
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.